Should biological companies be required to screen their orders to ensure that they are going to reputable universities, institutes, or investigators?
2
How can tools like RNAi be handled so that their potential for misuse is minimized, but are still widely available to legitimate researchers?
3
What do you think of Dr. Hannons views on biosecurity and biosafety?
4
Do you think that RNAi poses a serious biosecurity threat?
5
Many scientists who work with RNAi do not consider it a dual-use technology. Do you think that this attitude should be changed and if so, how can it be changed?
